Landos Biopharma, Inc. Quarterly Return On Assets in % from Q3 2021 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Landos Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q1 2024.
  • Landos Biopharma, Inc. Return On Assets for the quarter ending March 31, 2024 was -63 %, a 5.51% decline year-over-year.
  • Landos Biopharma, Inc. annual Return On Assets for 2023 was -49.1 %, a 28% increase from 2022.
  • Landos Biopharma, Inc. annual Return On Assets for 2022 was -68.2 %, a 89.2% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -63 -3.29 -5.51% Jan 1, 2024 Mar 31, 2024
Q4 2023 -49.1 +19.1 +28% Oct 1, 2023 Dec 31, 2023
Q3 2023 -45.3 +32.6 +41.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 -48 +22.5 +31.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -59.7 -15.6 -35.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -68.2 -32.2 -89.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -77.9 -45.3 -139% Jul 1, 2022 Sep 30, 2022
Q2 2022 -70.6 Apr 1, 2022 Jun 30, 2022
Q1 2022 -44.1 Jan 1, 2022 Mar 31, 2022
Q4 2021 -36 Oct 1, 2021 Dec 31, 2021
Q3 2021 -32.6 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.